Sanofi unsuccessful in its opposition to Amgen's Australian patent applications

The first substantive Australian decision in the global dispute over Amgen’s PCSK9 antibody patents has now been handed down by the Australian Patent…

Related Keywords

Australia ,Australian ,Sanofiv Amgen ,Proprotein Convertase Subtilisin Kexin ,Amgen ,Australian Therapeutic Goods Administration ,Australian Parliament ,Australian Patent Office ,Binding Proteins ,Proprotein Convertase Subtilisin Kexin Type ,Patents Act ,Intellectual Property Laws Amendment ,Law ,Lawyers ,Legal ,Aw Firms ,Aw Updates ,Egal Updates ,Egal Developments ,Aw Developments ,Egal Newsletters ,Egal Current Awareness ,Deals ,Egal Advisers ,Egal Advisors ,Egal Directory ,Litigation ,